(Q36200059)

12 August 2017

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD. (English)

1 reference

12 August 2017

Pedro Pesini

1

1 reference

12 August 2017

Virginia Pérez-Grijalba

2

1 reference

12 August 2017

Inmaculada Monleón

3

1 reference

12 August 2017

Mercè Boada

4

1 reference

12 August 2017

Lluís Tárraga

5

1 reference

12 August 2017

Pablo Martínez-Lage

6

1 reference

12 August 2017

Itziar San-José

7

1 reference

12 August 2017

Manuel Sarasa

8

1 reference

12 August 2017

language of work or name

1 reference

16 August 2012

1 reference

International journal of Alzheimer's disease

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

604141

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

The clinical use of structural MRI in Alzheimer disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Relationships between biomarkers in aging and dementia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Performance characteristics of plasma amyloid-beta 40 and 42 assays

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Natural human antibodies to amyloid beta peptide

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Is plasma amyloid-beta a reliable biomarker for Alzheimer's disease?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Neurovascular mechanisms of Alzheimer's neurodegeneration

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

2 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Overall concordance correlation coefficient for evaluating agreement among multiple observers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Surfactant-induced conformational transition of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Plasma Abeta levels do not reflect brain Abeta levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3431090

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

22 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F604141

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

21 January 2018

1 reference

12 December 2020

Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma

1 reference

12 December 2020

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

12 December 2020

Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/604141

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22957297

1 reference